• حول MVID
    • ما هو MVID؟
    • التشخيص و معدل الانتشار
    • العلاج
    • علم الوراثة
  • موارد المريض
  • الأبحاث الخاصة بنا
  • للأطباء
  • معلومات عنا
    • من نكون
    • اتصل بنا
  • أخبار
  • العربية
    • English
    • Türkçe
Vanessa Research, Inc. Logo Vanessa Research, Inc. Logo
  • حول MVID
    • ما هو MVID؟
    • التشخيص و معدل الانتشار
    • العلاج
    • علم الوراثة
  • موارد المريض
  • الأبحاث الخاصة بنا
  • للأطباء
  • معلومات عنا
    • من نكون
    • اتصل بنا
  • أخبار
  • العربية
    • English
    • Türkçe
    يوليو 26, 2018 - Hamden, Connecticut

    Vanessa Research announces new educational website on microvillus inclusion disease

    September 15, 2017 Hamden, Connecticut – Vanessa Research, Inc. (VRI), has announced the launch of a new educational website on microvillus inclusion disease or MVID – a rare, lethal genetic disorder that causes severe and chronic diarrhea in young babies and children. The goal of the site is to share resources with families and patients living with the daily…

    Read more
    يوليو 26, 2018 - Hamden, Connecticut

    New MVID Educational Video from Vanessa Research

    Hamden, Connecticut – Vanessa Research Inc. (VRI), has announced the launch of a new educational video (link) on microvillus inclusion disease (MVID) – a rare, genetic intestinal disease that causes severe diarrhea in young babies, and it is resistant to treatment. The loss of fluids is so rapid that life-threatening dehydration occurs within days or…

    Read more
    يوليو 26, 2018 - Hamden, Connecticut

    Vanessa Research Inc. Announces Launch of MVID Educational Website and Video in Turkish Language

    Hamden, CT – Vanessa Research Inc. (VRI) is pleased to announce the launch of its educational website focused on microvillus inclusion disease (MVID) translated into the Turkish language. The website explains the mechanism of MVID, provides targeted resources both for doctors and caregivers, and publishes new scientific research and other pertinent news and information related…

    Read more
    يوليو 18, 2018 - Hamden, Connecticut

    New MVID Educational Video from Vanessa Research

    Hamden, Connecticut – Vanessa Research Inc. (VRI), has announced the launch of a new educational video (link) on microvillus inclusion disease (MVID) – a rare, genetic intestinal disease that causes severe diarrhea in young babies, and it is resistant to treatment. The loss of fluids is so rapid that life-threatening dehydration occurs within days or...
    Read more
    يوليو 18, 2018 - Hamden, Connecticut

    Vanessa Research VP of Research and Development to give Keynote Speech at Quinnipiac Rare Disease Day

    February 23, 2018 By Samantha Miller - This article originally published on wthn.com Quinnipiac University to hold Rare Disease Day lecture and panel discussion (WTNH) — Medical students at Quinnipiac University are bringing attention to rare diseases, and how it affects peoples’ lives. Quinnipiac University will be holding a Rare Disease Day lecture and panel discussion to...
    Read more
    • 1
    • 2
    • الصفحة التالية «

الاشتراك في النشرة الإخبارية

يكون لديك الحق في سحب موافقتك في أي وقت. ستشتمل كل رسالة إلكترونية نرسلها على رابط إلغاء الاشتراك بنقرة واحدة حتى تتمكن من مغادرة القائمة في أي وقت.

حول MVID

  • ما هو MVID؟
  • التشخيص و معدل الانتشار
  • العلاج
  • علم الوراثة

معلومات عنا

  • من نكون
  • سياسة الخصوصية
  • تعليمات الاستخدام

اتصل بنا

Please contact us via the form below. We will respond to all enquiries as quickly as possible

Vanessa Research, Inc. Logo Vanessa Research, Inc. Logo

© 2022 Vanessa Biotech. - هذا الموقع موجه فقط للمستهلكين الأمريكيين لمنتجات وخدمات أبحاث فانيسا بالولايات
المتحدة. هذا الموقع ليس موجها للمستهلكين خارج الولايات المتحدة

Our site uses cookies and other technologies so that we, and our partners, can remember you and understand how you use our site. Access our Privacy policy, as seen on every page, to see a complete list of these technologies and to tell us whether they can be used on your device. Further use of this site will be considered consent.